Attorney advertisingBriefCorporate & Governance
Delaware Chancery keeps $8.9 billion R1 RCM buyout stockholder claim alive
Responsible attorney: Lou Schwartz, Schwartz & Associates, PC, Atlanta, Georgia. intake@snalawyers.com
Vice Chancellor J. Travis Laster denied a motion to dismiss Count I of a consolidated stockholder suit challenging R1 RCM Inc.'s $8.9 billion take-private sale to TowerBrook Capital Partners LP and Ascension Health Alliance. The court found that the private equity firm and health system's joint investment vehicle could qualify as a controlling stockholder for fiduciary-duty purposes even though it held less than one-third of R1 RCM's voting shares, allowing the stockholder claim challenging the deal to proceed past the pleading stage.
Why it matters. The ruling signals Delaware courts' willingness to find controlling-stockholder status based on influence rather than raw voting percentage, a theory relevant to shareholders challenging other minority-stake buyouts led by private equity and strategic co-investors.
Sources
- Law360 secondary
- CourtListener opinion
Briefs summarize public developments. Unless stated otherwise, the firm is not counsel in the matters described, and allegations are not findings.
General information, not legal advice. Reading this article or using the intake assistant does not create an attorney-client relationship.